Opportunity Information: Apply for CDC RFA GH11 1158SUPP
Apply for CDC RFA GH11 1158SUPP
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Strengthening the National Institutes of Health in the Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Dec 10, 2015 and posted on Dec 10, 2015.
- Applicants must submit their applications by Feb 10, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $5,251,408.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Strengthening the National Institutes of Health in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a discretionary funding announcement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). It is listed under Funding Opportunity Number CDC RFA GH11-1158SUPP and falls within the health funding activity category, with the associated CFDA number 93.067. The core purpose signaled by the title is to build and reinforce the capacity of Mozambique's National Institutes of Health in support of HIV/AIDS-related public health goals aligned with PEPFAR, the U.S. government's major global initiative to address HIV/AIDS.
The opportunity was posted on December 10, 2015, and shares the same creation date, indicating it was publicly released and made available to potential applicants at that time. The application closing date was February 10, 2016, with no later extension shown, meaning proposals were due roughly two months after posting. The funding instrument type is listed as "Other," which typically suggests the award mechanism is not a standard cooperative agreement or grant category as labeled in some other CDC notices, and may involve specific terms, structures, or administrative arrangements unique to this supplemental or specialized funding action.
Financially, the announcement specifies an award ceiling of $5,251,408, and it anticipates making a single award (Expected Awards: 1). In practical terms, this indicates the CDC planned to fund one recipient up to the stated maximum amount, rather than distributing smaller awards to multiple organizations. The combination of a single expected award and a relatively large ceiling implies the project scope is substantial and likely designed to support a coordinated set of national-level activities rather than isolated, small-scale interventions.
Eligibility is described broadly as "Others," with additional clarification referenced in a separate text field titled "Additional Information on Eligibility." While that extra eligibility language is not included in the provided source data, the "Others" designation commonly signals that eligibility may be limited to specific categories not captured by standard applicant types, or that it is restricted to certain organizations based on programmatic, geographic, or partnership considerations. Because the award is tied to PEPFAR and explicitly references strengthening Mozambique's National Institutes of Health, it is reasonable to infer the intended applicant pool could include entities able to work directly with national public health institutions in Mozambique, potentially including governmental or quasi-governmental partners, local institutions, or other organizations designated in the detailed eligibility section.
Overall, the notice reflects a targeted CDC investment, under PEPFAR, to strengthen institutional public health capacity in Mozambique through one major award. Key identifying details include the administering agency (HHS-CDC), the opportunity number (CDC RFA GH11-1158SUPP), the public health program area (health; CFDA 93.067), the timeline (posted December 10, 2015; due February 10, 2016), the funding cap ($5,251,408), and the plan to make a single award, all of which point to a focused, high-impact capacity-strengthening effort centered on Mozambique's national public health infrastructure in the context of HIV/AIDS response.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Strengthening the National Institutes of Health in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)."
Which agency is offering this funding opportunity?
This is a discretionary funding announcement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA GH11-1158SUPP.
What is the CFDA number associated with this opportunity?
The associated CFDA number is 93.067.
What funding activity category does this opportunity fall under?
This opportunity is listed under the health funding activity category.
What is the overall purpose of this funding opportunity?
Based on the title and description provided, the purpose is to strengthen and build capacity at Mozambique's National Institutes of Health in support of HIV/AIDS-related public health goals aligned with PEPFAR.
How is this opportunity connected to PEPFAR?
The opportunity is explicitly issued "under the President's Emergency Plan for AIDS Relief (PEPFAR)," indicating it supports HIV/AIDS response goals that align with the U.S. government's PEPFAR initiative.
When was this opportunity posted?
The opportunity was posted on December 10, 2015.
What is the application due date?
The application closing date was February 10, 2016.
Was there an extension to the application deadline?
No later extension is shown in the provided information. Based on the data provided, proposals were due on February 10, 2016.
How long did applicants have to apply after the posting date?
Based on the dates provided (posted December 10, 2015; due February 10, 2016), applicants had roughly two months to submit proposals.
What type of funding instrument is used for this opportunity?
The funding instrument type is listed as "Other."
What does it mean that the funding instrument type is listed as "Other"?
Based on the provided description, "Other" typically indicates the award mechanism is not a standard category (such as a typical grant or cooperative agreement as labeled in some CDC notices) and may involve specific terms, structures, or administrative arrangements unique to this supplemental or specialized funding action.
What is the maximum amount of funding available (award ceiling)?
The award ceiling is $5,251,408.
How many awards does CDC expect to make under this announcement?
CDC anticipated making a single award (Expected Awards: 1).
Does this opportunity fund multiple recipients or just one?
Based on the provided information (Expected Awards: 1), CDC planned to fund one recipient, up to the award ceiling.
What does it imply that only one award was expected?
Based on the information provided, a single expected award combined with a relatively large funding ceiling suggests a substantial project scope intended to support coordinated, national-level activities rather than multiple smaller, separate awards.
Who is eligible to apply?
Eligibility is described as "Others."
Is there additional eligibility detail available?
The listing notes an "Additional Information on Eligibility" field with further clarification, but that specific language is not included in the information provided here.
What might the "Others" eligibility category indicate?
Based on the description provided, "Others" commonly suggests eligibility may be limited to specific categories not captured by standard applicant types, or it may be restricted based on programmatic, geographic, or partnership considerations. The exact eligible entities cannot be confirmed from the provided text because the additional eligibility language is not included.
Is this opportunity focused on a specific country or location?
Yes. The title specifies the Republic of Mozambique, and the described purpose centers on strengthening Mozambique's National Institutes of Health.
Is this opportunity specifically about HIV/AIDS?
Yes. The opportunity references PEPFAR and is described as supporting HIV/AIDS-related public health goals.
What are the key identifiers someone would use to reference this opportunity?
Key identifiers provided include: HHS-CDC as the administering agency, the Funding Opportunity Number CDC RFA GH11-1158SUPP, CFDA 93.067, the posting date (December 10, 2015), the closing date (February 10, 2016), the award ceiling ($5,251,408), and the expected number of awards (1).
Is this a discretionary funding announcement?
Yes. The opportunity is described as a discretionary funding announcement issued by HHS-CDC.
What does the timeline suggest about the status of this opportunity?
Based on the provided dates (posted December 10, 2015 and closed February 10, 2016), the application window has already passed.
Browse more opportunities from the same category: Health
Next opportunity: FY 2016 Study of the U.S. Institutes for Student Leaders from Europe
Previous opportunity: DRL: Interfaith Programming in Eastern and Central Europe
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 1158SUPP
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 1158SUPP) also looked into and applied for these:
| Funding Opportunity |
|---|
| NEI Clinical Study Planning Grant Program (R34) Apply for PA 16 038 Funding Number: PA 16 038 Agency: HHS-NIH11 Category: Health Funding Amount: $150,000 |
| Novel Nucleic Acid Sequencing Technology Development - Direct to Phase II (R44) Apply for RFA HG 15 039 Funding Number: RFA HG 15 039 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Applied Research Toward Zero Suicide Healthcare Systems (R01) Apply for RFA MH 16 800 Funding Number: RFA MH 16 800 Agency: HHS-NIH11 Category: Health Funding Amount: $600,000 |
| Comprehensive Community-Based HIV Prevention, Linkage, and Retention Services for Key Populations and Adolescent Girls and Young Women in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1652 Funding Number: CDC RFA GH16 1652 Agency: HHS-CDC-CGH Category: Health Funding Amount: $630,000 |
| NHLBI Early Investigator Award (EIA) (R35) Apply for RFA HL 16 025 Funding Number: RFA HL 16 025 Agency: HHS-NIH11 Category: Health Funding Amount: $600,000 |
| Supporting Implementation of HIV and TB Services for Epidemic Control in the Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1632 Funding Number: CDC RFA GH16 1632 Agency: HHS-CDC-CGH Category: Health Funding Amount: $80,000,000 |
| Enhancing the Government of India’s Capacity to Scale Up and Improve Comprehensive HIV Service Package Quality for People Who Inject Drugs under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 154202CONT16 Funding Number: CDC RFA GH15 154202CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Flex Rural Veterans Health Access Program Apply for HRSA 16 015 Funding Number: HRSA 16 015 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Targeted Capacity Expansion-Peer-to-Peer (Short Title: TCE-PTP) Apply for TI 16 008 Funding Number: TI 16 008 Agency: HHS-SAMHS Category: Health Funding Amount: $250,000 |
| Implementing Comprehensive Community Based HIV/AIDS Prevention, Care and Treatment Services in Priority Areas in the Republic of Zambia under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1668 Funding Number: CDC RFA GH16 1668 Agency: HHS-CDC-CGH Category: Health Funding Amount: $2,500,000 |
| Cooperative Agreements for Adolescent and Transitional Aged Youth Treatment Implementation [Youth Treatment – Implementation (Short Title –YT-I)] Apply for TI 16 006 Funding Number: TI 16 006 Agency: HHS-SAMHS Category: Health Funding Amount: $800,000 |
| Scholarships for Disadvantaged Students (SDS) Apply for HRSA 16 069 Funding Number: HRSA 16 069 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Early HIV Treatment to Optimize Patient Health and HIV Prevention Apply for RFA PS 16 006 Funding Number: RFA PS 16 006 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $495,000 |
| Academic Units for Primary Care Training and Enhancement Apply for HRSA 16 041 Funding Number: HRSA 16 041 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp) Apply for PA 16 013 Funding Number: PA 16 013 Agency: HHS-NIH11 Category: Health Funding Amount: $100,000 |
| Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Western Region and Turkana County of the Republic of Kenya under the President’s Emergency Plan for AIDS R Apply for CDC RFA GH16 1619 Funding Number: CDC RFA GH16 1619 Agency: HHS-CDC-CGH Category: Health Funding Amount: $103,000,000 |
| NHLBI Clinical Trial Pilot Studies (R34) Apply for PAR 16 037 Funding Number: PAR 16 037 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Pulmonary and Cardiovascular Consequences of Inhaled Nicotine (R01) Apply for RFA HL 17 008 Funding Number: RFA HL 17 008 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Evaluating the Impact of Non-pharmaceutical Measures on the Incidence of Influenza-like Illness (ILI) among K-12 Students in the United States Apply for RFA CK 16 005 Funding Number: RFA CK 16 005 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $500,000 |
| Novel Genomic Technology Development Direct to Phase II SBIR (R44) Apply for PAR 16 017 Funding Number: PAR 16 017 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 1158SUPP", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.